Hepatitis C Virus (HCV) Testing Market
A Detailed Analysis of Hepatitis C Virus (HCV) Testing Market by Immunoassays-based Hepatitis C Virus Testing, Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing, and Other Hepatitis C Virus Testing Techniques
Interested in exploring key trends and breakthroughs in Hepatitis C Virus (HCV) Testing? FMI presents its exhaustive findings on the subject
Hepatitis C Virus (HCV) Testing Market Outlook (2023 to 2033)
The global hepatitis C virus (HCV) testing market size is expected to accumulate US$ 785.3 million in value by 2023 end. During the forecast period ranging from 2023 to 2033, a CAGR worth 5.4% has been projected for the market, with an expected closing value worth US$ 1,326.7 million. From 2018 to 2022, the industry unfolded at a value CAGR worth 4.6%.
The growing burden of infectious diseases on the global healthcare system is a significant consideration, with developing countries bearing a disproportionate share of the burden. Over time, the burden of hepatitis C virus infection has accelerated. According to the Institute of Liver and Biliary Sciences India, around 3% of the world's population is infected with the hepatitis C virus.
In 80 percent of infected patients, HCV did cause chronic infection. Initial hepatitis C virus testing employs serological assays to detect antibodies against HCV in blood samples. According to the Centers for Disease Control and Prevention (CDC) guidelines for hepatitis C screening, a cut-off ratio for anti-HPV antibodies is added, which aids in the selection of additional assays for confirmation of screening results.
The Nucleic Acid Amplification Test (NAT) is used to confirm and determine viral load. Regarding all constructive HCV antibody tests, an RNA test is performed. HCV genotyping tests are used in clinical HPV management to determine viral load and optimal treatment duration. Also, the use of non-sterile needles for tattooing and body piercing is a common cause of hepatitis C virus infection spread.
| Attributes | Key Statistics |
|---|---|
|
Global Market CAGR (2023 to 2033) |
5.4% |
|
Anticipated Market Value (2023) |
US$ 785.3 million |
|
Global Market (2033) |
US$ 1,326.7 million |
|
Global Market Attraction |
The rising prevalence of hepatitis C virus infection fueled by inadequate blood donation strategies |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Factors Spearheading the Global Hepatitis C Virus (HCV) Testing Market
The rising prevalence of hepatitis C virus infection is the primary driver of the global hepatitis C virus testing market. Inadequate blood donation strategies are the leading cause of hepatitis C virus infection. Also, hepatitis C screening is required before organ donation, and growing organ donation projects around the world are expected to drive future growth.
The introduction of point-of-care testing products for HCV testing raises the potential for HCV testing kits. The FDA approved the OraQuick HCV Rapid Antibody Test in 2010, and it is now widely used as an alternative to enzyme immunoassay testing for HCV. Also, the use of new electrochemical immuno-sensor and nano-sensor technologies in HPV testing is expected to change current practices.
Factors Stunting the Global Hepatitis C Virus (HCV) Testing Market
Factors that are limiting the adoption of hepatitis C virus testing include:
- Insufficient insurance coverage for hepatitis C testing
- Limited access to regular healthcare
Find your sweet spots for generating winning opportunities in this market.
North America Emerging as an Opportunistic Hepatitis C Virus (HCV) Testing Market
| Country/ Region | Market Share (2022) |
|---|---|
|
North America |
33.4% |
|
The United States |
29.5% |
An estimated 12.5-40% of detained people in North America have HCV-antibody positivity, supporting the recommendation to screen this population for HCV infection and increasing market demand.
Infection with the Hepatitis C virus (HCV) is a leading cause of morbidity and mortality in the United States. HCV is primarily transmitted via parenteral exposure to infectious blood or body fluids containing blood, most commonly through injection drug use. With 8-12 weeks of all-oral medication regimens, direct-acting antiviral treatment can result in a virologic cure in most people. This factor is increasing market demand in North America.
HCV infection rates nearly doubled among women with live births in North America between 2009 and 2014, as new HCV infections increased among reproductive-aged adults. As a result, this factor is expected to drive market growth in this region. As per Future Market Insights, North America is likely to account for more than 33.4% of the global Hepatitis C virus testing market in 2023.
Demand for Hepatitis C Virus (HCV) Testing Burgeoning in Europe
| Attribute | Details |
|---|---|
|
Europe’s Market Share (2022) |
30.7% |
|
Germany’s Market Share (2022) |
10% |
|
The United Kingdom’s Forecast CAGR (2023 to 2033) |
5.7% |
In 2023, Europe is forecasted to account for more than 30.7% share in the hepatitis C virus testing market, and is projected to maintain this growth throughout the forecast period, states Future Market Insights.
According to a research paper published in the medical journal BMJ Open in August 2020, HCV diagnosis rates in Germany are projected to exceed 70% by 2030 under the current approach. Such encouraging trends in HCV testing in the country are expected to significantly aid market growth during the forecast period.
In Europe, Hepatitis C is one of the most common infectious diseases. Several initiatives in the region have been inaugurated to better understand disease trends, such as prevalence and the most widely known genotypes. It is a liver disease caused by the hepatitis C virus (HCV), and it can contribute to the development of liver cancer if left untreated.
Germany has historically had a low prevalence of hepatitis C than developing countries. However, the country's demographics have changed in recent years. Also, the increasing influx of migrants and rising drug abuse through injections among the general population are projected to augment the country's hepatitis C prevalence.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Start-ups Adding Value to the Global Market
The swelling dispersion of start-ups in the hepatitis C virus testing market has improved product quality and elevated global sales. Besides, to gain a competitive edge, new start-ups are working on novel developments and launching new products. Moreover, some notable players offering hepatitis C virus testing kits are as follows:
| Start-up’s Name | Product in Detail |
|---|---|
|
NATSpert |
NATSpert, established in 2017 in Pune, India, is a developer of blood detection kits for viral diseases. Its product- NATSpert ID TripleH is a qualitative, real-time PCR test for the simultaneous detection of HIV, HBV, and HCV respectively. The kit comes in a single tube format and allows for screening of HIV type 1 group M-RNA, HIV-1 group-O RNA, HIV-2 RNA, Hepatitis C Virus RNA, and Hepatitis B Virus DNA in human blood plasma. |
|
HepC |
Founded in 2005, HepC is a developer of antiviral biologic products. The company deploys IBDV, a non-pathogenic double-stranded RNA virus. This virus acts as a master activator of antiviral gene responses as its primary vector system. Its product development includes HC001 for treating advanced chronic viral hepatitis caused by HBV and HCV infections. |
Key Players Leading the Hepatitis C Virus Testing Marketplace
Some of the manufacturers identified in the global hepatitis C virus testing market include OraSure Technologies, Inc., Abbott Laboratories Inc., Siemens Healthcare GmbH, Bio Rad Laboratories Inc., Ortho Clinical Diagnostic Inc. (Johnson & Johnson), Bayer AG, QIAGEN N.V., Thermo Fisher Scientific Inc., BioGenex, AccuQuick, Roche Diagnostics (H. Hoffman-La Roche Ltd.), STD Rapid Test Kits, etc. among others.
Discover Recent Occurrences Shaping the Market
| Organization’s Name | Nature of Development |
|---|---|
|
Roche |
Roche releases Novel Hepatitis C Virus Diagnostic test. |
|
WHO and the University of BRISTOL |
WHO Collaborated with the University of BRISTOL to lead the research related to HCV. |
|
Mylab |
Pune’s Mylab Introduces Rapid Test Kits to rapidly Detect HCV, HIV, and Syphilis. |
|
J MITRA |
J MITRA releases 4th Gen Elisa-based HCV Test. |
|
Access Bio Inc. and Atomo Diagnostics |
Access Bio Inc. and Atomo Diagnostics revealed the development of RDT. |
|
Gilead Sciences Inc. |
Gilead Sciences Inc. reported the HepConnect Initiative. |
| Organization’s Name | Key Particulars About the Event |
|---|---|
|
Roche |
Roche has introduced a new dual antibody and antigen diagnostic testing called Elecys HCV Duo immunoassay to treat the hepatitis C virus. The test is launched in countries that permit the CE Mark. |
|
WHO and the University of BRISTOL |
A new study exhibits the advantages of a quick clinic-based diagnostic test for HCV infection over a general laboratory-based test. The discoveries from the study have resulted in the WHO recommending the adoption of the point-of-care (POC) HCV test. These rapid tests make HCV diagnosis close and accessible to the community. |
|
Mylab |
Mylab Discovery Solutions, a Pune-based company, announced in February 2023, that it is releasing three new rapid tests to quickly detect STIs. STIs pose a grave hurdle as WHO predicts that the caseload of STIs is going to reach 1 million/day, globally. |
|
J MITRA |
In September 2022, J Mitra, which is an IVD Company, introduced the HCV Gen 4 Ag & Ab Microlisa, which is a 4th generation Elisa-based HCV Test. The kit aims to screen blood donations to detect and discard infection units of blood. The kit is also used as a clinical diagnostic test for Hepatitis C. |
|
Access Bio Inc. and Atomo Diagnostics |
Access Bio Inc. and Atomo Diagnostics announced the development of a rapid diagnostic test (RDT) for screening for the hepatitis C virus in April 2019. (HCV). The tests were commercially available by the end of this year 2019. |
|
Gilead Sciences Inc. |
Gilead Sciences Inc. announced the HepConnect initiative to reduce hepatitis C infections in Great Appalachia in March 2019. |
Report Scope
| Report Attributes | Details |
|---|---|
|
Growth Rate |
CAGR of 5.4% from 2023 to 2033 |
|
Market Value in 2023 |
US$ 785.3 million |
|
Market Value in 2033 |
US$ 1,326.7 million |
|
Base Year for Estimation |
2022 |
|
Historical Period |
2018 to 2022 |
|
Forecast Period |
2023 to 2033 |
|
Quantitative Units |
Revenue in US$ million and CAGR from 2023 to 2033 |
|
Report Coverage |
Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
|
|
Customization |
Available Upon Request |
Key Segments Covered in the Hepatitis C Virus (HCV) Testing Market Survey
By Technique:
- Immunoassays-based Hepatitis C Virus Testing
- Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
- Other Hepatitis C Virus Testing Techniques
By Test Type:
- HCV Antibody Testing
- HCV Viral Load Testing
- HCV Genotyping Testing
By End User:
- Hospitals
- Diagnostic Centers
- Blood Donation Centers
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- The Middle East & Africa
Frequently Asked Questions
How Big will the the Hepatitis C Virus (HCV) Testing Market?
This market is estimated to reach US$ 1,326.7 million by 2033.
What is North America’s Market Growth Outlook?
North America expanded at a market share of 33.4% in 2022.
What Restrains the Market Growth?
Limited access to regular healthcare restrains the market growth.
Which is the Top Driver in the Market?
Infectious diseases drive sales, hitting global healthcare and developing nations.
Which Region holds Lucrative Opportunities?
North America holds a substantial share of the market.
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Technique 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Technique, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technique, 2023 to 2033 5.3.1. Immunoassays-based Hepatitis C Virus Testing 5.3.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing 5.3.3. Other Hepatitis C Virus Testing Techniques 5.4. Y-o-Y Growth Trend Analysis By Technique, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Technique, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2023 to 2033 6.3.1. HCV Antibody Testing 6.3.2. HCV Viral Load Testing 6.3.3. HCV Genotyping Testing 6.4. Y-o-Y Growth Trend Analysis By Test Type, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Test Type, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033 7.3.1. Hepatitis C Virus Testing in Hospitals 7.3.2. Hepatitis C Virus Testing in Diagnostic Centers 7.3.3. Hepatitis C Virus Testing in Blood Donation Centers 7.4. Y-o-Y Growth Trend Analysis By End User , 2018 to 2022 7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Technique 9.2.3. By Test Type 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Technique 9.3.3. By Test Type 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Technique 10.2.3. By Test Type 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Technique 10.3.3. By Test Type 10.3.4. By End User 10.4. Key Takeaways 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. UK 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Technique 11.2.3. By Test Type 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Technique 11.3.3. By Test Type 11.3.4. By End User 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Technique 12.2.3. By Test Type 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Technique 12.3.3. By Test Type 12.3.4. By End User 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Technique 13.2.3. By Test Type 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Technique 13.3.3. By Test Type 13.3.4. By End User 13.4. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Technique 14.2.3. By Test Type 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Technique 14.3.3. By Test Type 14.3.4. By End User 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Technique 15.2.3. By Test Type 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Technique 15.3.3. By Test Type 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Technique 16.1.2.2. By Test Type 16.1.2.3. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Technique 16.2.2.2. By Test Type 16.2.2.3. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Technique 16.3.2.2. By Test Type 16.3.2.3. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Technique 16.4.2.2. By Test Type 16.4.2.3. By End User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Technique 16.5.2.2. By Test Type 16.5.2.3. By End User 16.6. UK 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Technique 16.6.2.2. By Test Type 16.6.2.3. By End User 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Technique 16.7.2.2. By Test Type 16.7.2.3. By End User 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Technique 16.8.2.2. By Test Type 16.8.2.3. By End User 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Technique 16.9.2.2. By Test Type 16.9.2.3. By End User 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Technique 16.10.2.2. By Test Type 16.10.2.3. By End User 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Technique 16.11.2.2. By Test Type 16.11.2.3. By End User 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Technique 16.12.2.2. By Test Type 16.12.2.3. By End User 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Technique 16.13.2.2. By Test Type 16.13.2.3. By End User 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Technique 16.14.2.2. By Test Type 16.14.2.3. By End User 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Technique 16.15.2.2. By Test Type 16.15.2.3. By End User 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Technique 16.16.2.2. By Test Type 16.16.2.3. By End User 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Technique 16.17.2.2. By Test Type 16.17.2.3. By End User 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Technique 16.18.2.2. By Test Type 16.18.2.3. By End User 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Technique 16.19.2.2. By Test Type 16.19.2.3. By End User 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Technique 16.20.2.2. By Test Type 16.20.2.3. By End User 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Technique 16.21.2.2. By Test Type 16.21.2.3. By End User 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2022 16.22.2.1. By Technique 16.22.2.2. By Test Type 16.22.2.3. By End User 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2022 16.23.2.1. By Technique 16.23.2.2. By Test Type 16.23.2.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Technique 17.3.3. By Test Type 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. OraSure Technologies, Inc. 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Abbott Laboratories Inc. 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Siemens Healthcare GmbH 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Bio Rad Laboratories Inc. 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Ortho Clinical Diagnostic Inc. (Johnson & Johnson) 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Bayer AG 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. QIAGEN N.V. 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Thermo Fisher Scientific Inc. 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. BioGenex 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. AccuQuick, 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.11. Roche Diagnostics (F. Hoffman-La Roche Ltd.) 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.12. STD Rapid Test Kits 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033 Table 2: Global Market Value (US$ Million) Forecast by Technique, 2018 to 2033 Table 3: Global Market Value (US$ Million) Forecast by Test Type, 2018 to 2033 Table 4: Global Market Value (US$ Million) Forecast by End User , 2018 to 2033 Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 6: North America Market Value (US$ Million) Forecast by Technique, 2018 to 2033 Table 7: North America Market Value (US$ Million) Forecast by Test Type, 2018 to 2033 Table 8: North America Market Value (US$ Million) Forecast by End User , 2018 to 2033 Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 10: Latin America Market Value (US$ Million) Forecast by Technique, 2018 to 2033 Table 11: Latin America Market Value (US$ Million) Forecast by Test Type, 2018 to 2033 Table 12: Latin America Market Value (US$ Million) Forecast by End User , 2018 to 2033 Table 13: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 14: Western Europe Market Value (US$ Million) Forecast by Technique, 2018 to 2033 Table 15: Western Europe Market Value (US$ Million) Forecast by Test Type, 2018 to 2033 Table 16: Western Europe Market Value (US$ Million) Forecast by End User , 2018 to 2033 Table 17: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 18: Eastern Europe Market Value (US$ Million) Forecast by Technique, 2018 to 2033 Table 19: Eastern Europe Market Value (US$ Million) Forecast by Test Type, 2018 to 2033 Table 20: Eastern Europe Market Value (US$ Million) Forecast by End User , 2018 to 2033 Table 21: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 22: South Asia and Pacific Market Value (US$ Million) Forecast by Technique, 2018 to 2033 Table 23: South Asia and Pacific Market Value (US$ Million) Forecast by Test Type, 2018 to 2033 Table 24: South Asia and Pacific Market Value (US$ Million) Forecast by End User , 2018 to 2033 Table 25: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 26: East Asia Market Value (US$ Million) Forecast by Technique, 2018 to 2033 Table 27: East Asia Market Value (US$ Million) Forecast by Test Type, 2018 to 2033 Table 28: East Asia Market Value (US$ Million) Forecast by End User , 2018 to 2033 Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 30: Middle East and Africa Market Value (US$ Million) Forecast by Technique, 2018 to 2033 Table 31: Middle East and Africa Market Value (US$ Million) Forecast by Test Type, 2018 to 2033 Table 32: Middle East and Africa Market Value (US$ Million) Forecast by End User , 2018 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Technique, 2023 to 2033 Figure 2: Global Market Value (US$ Million) by Test Type, 2023 to 2033 Figure 3: Global Market Value (US$ Million) by End User , 2023 to 2033 Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033 Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033 Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 8: Global Market Value (US$ Million) Analysis by Technique, 2018 to 2033 Figure 9: Global Market Value Share (%) and BPS Analysis by Technique, 2023 to 2033 Figure 10: Global Market Y-o-Y Growth (%) Projections by Technique, 2023 to 2033 Figure 11: Global Market Value (US$ Million) Analysis by Test Type, 2018 to 2033 Figure 12: Global Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033 Figure 13: Global Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033 Figure 14: Global Market Value (US$ Million) Analysis by End User , 2018 to 2033 Figure 15: Global Market Value Share (%) and BPS Analysis by End User , 2023 to 2033 Figure 16: Global Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033 Figure 17: Global Market Attractiveness by Technique, 2023 to 2033 Figure 18: Global Market Attractiveness by Test Type, 2023 to 2033 Figure 19: Global Market Attractiveness by End User , 2023 to 2033 Figure 20: Global Market Attractiveness by Region, 2023 to 2033 Figure 21: North America Market Value (US$ Million) by Technique, 2023 to 2033 Figure 22: North America Market Value (US$ Million) by Test Type, 2023 to 2033 Figure 23: North America Market Value (US$ Million) by End User , 2023 to 2033 Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033 Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 28: North America Market Value (US$ Million) Analysis by Technique, 2018 to 2033 Figure 29: North America Market Value Share (%) and BPS Analysis by Technique, 2023 to 2033 Figure 30: North America Market Y-o-Y Growth (%) Projections by Technique, 2023 to 2033 Figure 31: North America Market Value (US$ Million) Analysis by Test Type, 2018 to 2033 Figure 32: North America Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033 Figure 33: North America Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033 Figure 34: North America Market Value (US$ Million) Analysis by End User , 2018 to 2033 Figure 35: North America Market Value Share (%) and BPS Analysis by End User , 2023 to 2033 Figure 36: North America Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033 Figure 37: North America Market Attractiveness by Technique, 2023 to 2033 Figure 38: North America Market Attractiveness by Test Type, 2023 to 2033 Figure 39: North America Market Attractiveness by End User , 2023 to 2033 Figure 40: North America Market Attractiveness by Country, 2023 to 2033 Figure 41: Latin America Market Value (US$ Million) by Technique, 2023 to 2033 Figure 42: Latin America Market Value (US$ Million) by Test Type, 2023 to 2033 Figure 43: Latin America Market Value (US$ Million) by End User , 2023 to 2033 Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033 Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 48: Latin America Market Value (US$ Million) Analysis by Technique, 2018 to 2033 Figure 49: Latin America Market Value Share (%) and BPS Analysis by Technique, 2023 to 2033 Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Technique, 2023 to 2033 Figure 51: Latin America Market Value (US$ Million) Analysis by Test Type, 2018 to 2033 Figure 52: Latin America Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033 Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033 Figure 54: Latin America Market Value (US$ Million) Analysis by End User , 2018 to 2033 Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User , 2023 to 2033 Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033 Figure 57: Latin America Market Attractiveness by Technique, 2023 to 2033 Figure 58: Latin America Market Attractiveness by Test Type, 2023 to 2033 Figure 59: Latin America Market Attractiveness by End User , 2023 to 2033 Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 61: Western Europe Market Value (US$ Million) by Technique, 2023 to 2033 Figure 62: Western Europe Market Value (US$ Million) by Test Type, 2023 to 2033 Figure 63: Western Europe Market Value (US$ Million) by End User , 2023 to 2033 Figure 64: Western Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 65: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 66: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 67: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 68: Western Europe Market Value (US$ Million) Analysis by Technique, 2018 to 2033 Figure 69: Western Europe Market Value Share (%) and BPS Analysis by Technique, 2023 to 2033 Figure 70: Western Europe Market Y-o-Y Growth (%) Projections by Technique, 2023 to 2033 Figure 71: Western Europe Market Value (US$ Million) Analysis by Test Type, 2018 to 2033 Figure 72: Western Europe Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033 Figure 73: Western Europe Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033 Figure 74: Western Europe Market Value (US$ Million) Analysis by End User , 2018 to 2033 Figure 75: Western Europe Market Value Share (%) and BPS Analysis by End User , 2023 to 2033 Figure 76: Western Europe Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033 Figure 77: Western Europe Market Attractiveness by Technique, 2023 to 2033 Figure 78: Western Europe Market Attractiveness by Test Type, 2023 to 2033 Figure 79: Western Europe Market Attractiveness by End User , 2023 to 2033 Figure 80: Western Europe Market Attractiveness by Country, 2023 to 2033 Figure 81: Eastern Europe Market Value (US$ Million) by Technique, 2023 to 2033 Figure 82: Eastern Europe Market Value (US$ Million) by Test Type, 2023 to 2033 Figure 83: Eastern Europe Market Value (US$ Million) by End User , 2023 to 2033 Figure 84: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 85: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 88: Eastern Europe Market Value (US$ Million) Analysis by Technique, 2018 to 2033 Figure 89: Eastern Europe Market Value Share (%) and BPS Analysis by Technique, 2023 to 2033 Figure 90: Eastern Europe Market Y-o-Y Growth (%) Projections by Technique, 2023 to 2033 Figure 91: Eastern Europe Market Value (US$ Million) Analysis by Test Type, 2018 to 2033 Figure 92: Eastern Europe Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033 Figure 93: Eastern Europe Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033 Figure 94: Eastern Europe Market Value (US$ Million) Analysis by End User , 2018 to 2033 Figure 95: Eastern Europe Market Value Share (%) and BPS Analysis by End User , 2023 to 2033 Figure 96: Eastern Europe Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033 Figure 97: Eastern Europe Market Attractiveness by Technique, 2023 to 2033 Figure 98: Eastern Europe Market Attractiveness by Test Type, 2023 to 2033 Figure 99: Eastern Europe Market Attractiveness by End User , 2023 to 2033 Figure 100: Eastern Europe Market Attractiveness by Country, 2023 to 2033 Figure 101: South Asia and Pacific Market Value (US$ Million) by Technique, 2023 to 2033 Figure 102: South Asia and Pacific Market Value (US$ Million) by Test Type, 2023 to 2033 Figure 103: South Asia and Pacific Market Value (US$ Million) by End User , 2023 to 2033 Figure 104: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033 Figure 105: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 106: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 107: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 108: South Asia and Pacific Market Value (US$ Million) Analysis by Technique, 2018 to 2033 Figure 109: South Asia and Pacific Market Value Share (%) and BPS Analysis by Technique, 2023 to 2033 Figure 110: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Technique, 2023 to 2033 Figure 111: South Asia and Pacific Market Value (US$ Million) Analysis by Test Type, 2018 to 2033 Figure 112: South Asia and Pacific Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033 Figure 113: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033 Figure 114: South Asia and Pacific Market Value (US$ Million) Analysis by End User , 2018 to 2033 Figure 115: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User , 2023 to 2033 Figure 116: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033 Figure 117: South Asia and Pacific Market Attractiveness by Technique, 2023 to 2033 Figure 118: South Asia and Pacific Market Attractiveness by Test Type, 2023 to 2033 Figure 119: South Asia and Pacific Market Attractiveness by End User , 2023 to 2033 Figure 120: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033 Figure 121: East Asia Market Value (US$ Million) by Technique, 2023 to 2033 Figure 122: East Asia Market Value (US$ Million) by Test Type, 2023 to 2033 Figure 123: East Asia Market Value (US$ Million) by End User , 2023 to 2033 Figure 124: East Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 125: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 126: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 127: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 128: East Asia Market Value (US$ Million) Analysis by Technique, 2018 to 2033 Figure 129: East Asia Market Value Share (%) and BPS Analysis by Technique, 2023 to 2033 Figure 130: East Asia Market Y-o-Y Growth (%) Projections by Technique, 2023 to 2033 Figure 131: East Asia Market Value (US$ Million) Analysis by Test Type, 2018 to 2033 Figure 132: East Asia Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033 Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033 Figure 134: East Asia Market Value (US$ Million) Analysis by End User , 2018 to 2033 Figure 135: East Asia Market Value Share (%) and BPS Analysis by End User , 2023 to 2033 Figure 136: East Asia Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033 Figure 137: East Asia Market Attractiveness by Technique, 2023 to 2033 Figure 138: East Asia Market Attractiveness by Test Type, 2023 to 2033 Figure 139: East Asia Market Attractiveness by End User , 2023 to 2033 Figure 140: East Asia Market Attractiveness by Country, 2023 to 2033 Figure 141: Middle East and Africa Market Value (US$ Million) by Technique, 2023 to 2033 Figure 142: Middle East and Africa Market Value (US$ Million) by Test Type, 2023 to 2033 Figure 143: Middle East and Africa Market Value (US$ Million) by End User , 2023 to 2033 Figure 144: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033 Figure 145: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 146: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 147: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 148: Middle East and Africa Market Value (US$ Million) Analysis by Technique, 2018 to 2033 Figure 149: Middle East and Africa Market Value Share (%) and BPS Analysis by Technique, 2023 to 2033 Figure 150: Middle East and Africa Market Y-o-Y Growth (%) Projections by Technique, 2023 to 2033 Figure 151: Middle East and Africa Market Value (US$ Million) Analysis by Test Type, 2018 to 2033 Figure 152: Middle East and Africa Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033 Figure 153: Middle East and Africa Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033 Figure 154: Middle East and Africa Market Value (US$ Million) Analysis by End User , 2018 to 2033 Figure 155: Middle East and Africa Market Value Share (%) and BPS Analysis by End User , 2023 to 2033 Figure 156: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033 Figure 157: Middle East and Africa Market Attractiveness by Technique, 2023 to 2033 Figure 158: Middle East and Africa Market Attractiveness by Test Type, 2023 to 2033 Figure 159: Middle East and Africa Market Attractiveness by End User , 2023 to 2033 Figure 160: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports
